Exhibit 32.1

                            CERTIFICATION OF PERIODIC
                  REPORT As adopted Pursuant to Section 906 of
                         the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q for the first quarter ended
September 30, 2005 of Integrated BioPharma, Inc. (the "Company") as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), E.
Gerald Kay, the Chief Executive Officer of Integrated BioPharma, Inc. certifies,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section
1350, that to his knowledge:

(1)           the Report  fully  complies  with the  requirements  of Section
              13(a) or 15(d) of the  Securities  Exchange Act of 1934 (15
              U.S.C. 78m or 78o(d)); and

(2)           the information  contained in the Report fairly presents, in all
              material  respects,  the financial  condition and results of
              operations of the Company.

This certification accompanies the Report pursuant to Section 906 of
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement has been provided to the Company and
will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.


Date: November 3, 2005               By: /s/ E. Gerald Kay
                                     ---------------------
                                     E. Gerald Kay,
                                     Chief Executive Officer